Deutsche Zeitschrift für Onkologie 2018; 50(01): 17-20
DOI: 10.1055/s-0044-101801
Forschung – Neues aus der Onkologie
PET/CT
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Nuklearmedizinische Untersuchung verbessert Erfolgskontrolle in der Brustkrebsbehandlung

Trine Lembrecht Jørgensen
Further Information

Publication History

Publication Date:
13 March 2018 (online)

Riedl CC, Pinker K, Ulaner GA, Ong LT, Baltzer P, Jochelson MS, McArthur HL, Gönen M, Dickler M, Weber WA. Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer. Eur J Nucl Med Mol Imaging 2017; doi: 10.1007/s00259-017-3703-7

Eine PET/CT-Untersuchung kann den Erfolg einer Brustkrebstherapie besser vorhersagen als eine Computertomographie (CT) allein. Dies belegt eine neue Studie mit 145 Patientinnen, die an fortgeschrittenem Brustkrebs litten. Demnach könnte das nuklearmedizinisch-radiologische Kombi-Verfahren den Therapieverlauf bei jeder vierten Brustkrebspatientin beeinflussen.

 
  • Literatur

  • 1 Europe in figures - Eurostat Yearbook, http://ec.europa.eu/eurostat/statisticsexplained/index.php/Europe_in_figures_-_Eurostat_yearbook , accessed 29/03/2017
  • 2 Engholm G, Ferlay J, Christensen N et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.3 (08.07.2016). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu. accessed on 29/03/2017
  • 3 Scher KS, Hurria A. Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol 2012; 30: 2036-2038
  • 4 Ewertz M, Christensen K, Engholm G. on behalf of the Academy of Geriatric Cancer Research (AgeCare). et al. Trends in cancer in the elderly population in Denmark 1980-2012. Special issue of the Academy of geriatric cancer research (AgeCare). Acta Oncologica 2016; 55 (Suppl. 01) 1-6
  • 5 Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev 2016; 25: 1029-1036
  • 6 Institute of Medicine. Delivering high-quality cancer care: charting a new course for a system in crisis. Washington (DC): The National Academies Press; 2013
  • 7 Lyons KD, Radomski MV, Alfano CM. et al. Delphi study to determine rehabilitation research priorities for older adults with cancer. Arch Phys Med Rehab 2017; 98: 904-914